Clinical Research Directory
Browse clinical research sites, groups, and studies.
UPLYFT For Lymphoma Survivors
Sponsor: Dana-Farber Cancer Institute
Summary
The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.
Official title: An Intervention for Fear of Cancer Recurrence for Lymphoma Survivors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
74
Start Date
2022-02-08
Completion Date
2026-08-31
Last Updated
2026-02-24
Healthy Volunteers
No
Conditions
Interventions
Interview with Clinicians
One time, qualitative interview of clinicians for feedback on UPLYFT intervention
Field Test of UPLYFT with Lymphoma Survivors
6 session of UPLYFT intervention with Lymphoma Survivors for feedback
Pilot of UPLYFT with Lymphoma Survivors
6 session of UPLYFT intervention with Lymphoma Survivors
Locations (1)
Dana-Farber Cancer Institute
Boston, Massachusetts, United States